Skip to main content
Journal cover image

Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction.

Publication ,  Journal Article
Keteyian, SJ; Isaac, D; Thadani, U; Roy, BA; Bensimhon, DR; McKelvie, R; Russell, SD; Hellkamp, AS; Kraus, WE; HF-ACTION Investigators,
Published in: Am Heart J
October 2009

BACKGROUND: To assess the safety of symptom-limited exercise testing in patients with New York Heart Association class II-IV heart failure symptoms due to left ventricular systolic dysfunction, we investigated the frequency of all-cause fatal and nonfatal major cardiovascular (CV) events among subjects enrolled in a prospective clinical trial (HF-ACTION). We hypothesized that exercise testing would be safe, as defined by a rate for all-cause death of <0.1 per 1,000 tests and a rate of nonfatal CV events <1.0 per 1,000 tests. METHODS: Before enrollment and at 3, 12, and 24 months after randomization, subjects were scheduled to complete a symptom-limited graded exercise test with open-circuit spirometry for analysis of expired gases. To ensure the accurate reporting of exercise test-related events, we report deaths and nonfatal major CV events per 1,000 tests at months 3, 12, or 24 after randomization. RESULTS: A total of 2,331 subjects were randomized into HF-ACTION. After randomization, 2,037 subjects completed 4,411 exercise tests. There were no test-related deaths, exacerbation of heart failure or angina requiring hospitalization, myocardial infarctions, strokes, or transient ischemic attacks. There was one episode each of ventricular fibrillation and sustained ventricular tachycardia. There were no exercise test-related implantable cardioverter defibrillator discharges requiring hospitalization. These findings correspond to zero deaths per 1,000 exercise tests and 0.45 nonfatal major CV events per 1,000 exercise tests (95% CI 0.11-1.81). CONCLUSIONS: In New York Heart Association class II-IV patients with severe left ventricular systolic dysfunction, we observed that symptom-limited exercise testing is safe based on no deaths and a rate of nonfatal major CV events that is <0.5 per 1,000 tests.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

October 2009

Volume

158

Issue

4 Suppl

Start / End Page

S72 / S77

Location

United States

Related Subject Headings

  • Ventricular Dysfunction, Left
  • Stroke Volume
  • Severity of Illness Index
  • Safety
  • Quality of Life
  • Prognosis
  • Middle Aged
  • Male
  • Humans
  • Heart Failure
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Keteyian, S. J., Isaac, D., Thadani, U., Roy, B. A., Bensimhon, D. R., McKelvie, R., … HF-ACTION Investigators, . (2009). Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J, 158(4 Suppl), S72–S77. https://doi.org/10.1016/j.ahj.2009.07.014
Keteyian, Steven J., Debra Isaac, Udho Thadani, Brad A. Roy, Daniel R. Bensimhon, Robert McKelvie, Stuart D. Russell, Anne S. Hellkamp, William E. Kraus, and William E. HF-ACTION Investigators. “Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction.Am Heart J 158, no. 4 Suppl (October 2009): S72–77. https://doi.org/10.1016/j.ahj.2009.07.014.
Keteyian SJ, Isaac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, et al. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J. 2009 Oct;158(4 Suppl):S72–7.
Keteyian, Steven J., et al. “Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction.Am Heart J, vol. 158, no. 4 Suppl, Oct. 2009, pp. S72–77. Pubmed, doi:10.1016/j.ahj.2009.07.014.
Keteyian SJ, Isaac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, Russell SD, Hellkamp AS, Kraus WE, HF-ACTION Investigators. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J. 2009 Oct;158(4 Suppl):S72–S77.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

October 2009

Volume

158

Issue

4 Suppl

Start / End Page

S72 / S77

Location

United States

Related Subject Headings

  • Ventricular Dysfunction, Left
  • Stroke Volume
  • Severity of Illness Index
  • Safety
  • Quality of Life
  • Prognosis
  • Middle Aged
  • Male
  • Humans
  • Heart Failure